[OurCrowd CEO Jon Medved in The Jerusalem Post] Expect a ‘renaissance’ in medical innovation, says OurCrowd chief
OurCrowd
MAY 9, 2020
Jonathan Medved, CEO of the Jerusalem-based global investment platform OurCrowd, told The Media Line that the outbreak had shifted the focus of many investors in a way that could have far-reaching implications for medical innovation. Read more here. The post [OurCrowd CEO Jon Medved in The Jerusalem Post] Expect a ‘renaissance’ in medical innovation, says OurCrowd chief appeared first on OurCrowd.
Let's personalize your content